Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
acyl CoA dehydrogenase deficiency
advances in neurology
adverse drug reaction
anticoagulant, treatment
anticoagulant, treatment in CVD
antioxidant
antiviral agents
arrhythmia, cardiac
arterial dissection
arterial dissection, carotid
arterial dissection, vertebral
arteritides
arthralgia
arylsulfatase A
aspartate aminotransferase
aspirin
aspirin, dose of
aspirin, failure of
ataxia
ataxia, cerebellar
ataxia, progressive
atherosclerosis, generalized
atherosclerosis, premature
atorvastatin
atrial fibrillation
autoantibodies
blacks
blood pressure
bruit
carbamazepine
cardiomyopathy
cardiovascular disease
carnitine deficiency
carnitine deficiency myopathy
carotid artery
carotid artery atherosclerosis
carotid artery atherosclerosis, pathogenesis
carotid artery atherosclerosis, regression
carotid artery disease
carotid artery disease, asymptomatic
carotid artery disease, noninvasive evaluation of
carotid artery intima-media thickness
carotid artery occlusion, bilateral
carotid artery occlusion, intracranial
carotid artery occlusion, neck
carotid artery plaque
carotid artery stenosis
carotid artery stenosis, intracranial
carotid siphon
carotid-siphon occlusion
case studies
CAT scan, abnormal
cataplexy
cataracts
CD4 counts
cerebellar lesion
cerebral atherosclerosis
cerebral blood flow
cerebral embolism
cerebral embolism, cardiac origin
cerebral infarction
cerebral infarction, hemorrhagic
cerebral infarction, subcortical
cerebral ischemia
cerebrotendinous xanthomatosis
cerebrovascular accident
cerebrovascular accident, classification
cerebrovascular accident, etiology
cerebrovascular accident, familial occurrence
cerebrovascular accident, incidence of
cerebrovascular accident, infancy and childhood
cerebrovascular accident, multiple
cerebrovascular accident, pathophysiology
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, racial differences
cerebrovascular accident, recurrent
cerebrovascular accident, secondary prevention
cerebrovascular accident, sex distribution
cerebrovascular accident, silent
cerebrovascular accident, vascular territory involved
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular accident, young adult
cerebrovascular disease
cerebrovascular disease, hypercholesterolemia in
cerebrovascular disease, predisposed factor in
cerebrovascular disease, risk factors in
cerebrovascular disease, treatment of
cervical spine injury
chest pain
children
cholesterol
cholesterol, HDL
cholesterol, LDL
cigarette smoking
Clinical Pathologic Conference(C.P.C.)
clofibrate
cognition
collagen vascular disease
complement
complement, serum
complications
congenital heart disease
controversies in neurology
cor pulmonale
cornea, abnormal
coronary artery disease
cortical infarction
cost effectiveness
coumarin
creatine phosphokinase(CPK)elevated
degenerative diseases of CNS
dementia
dementia, cerebrovascular disease causing
dementia, prevention of
diabetes mellitus
diabetes mellitus, neurologic manifestations of
diarrhea
diet
differential diagnosis
dilantin
dilantin, serum level
dissociated sensory loss
doppler
drug induced neurologic disorders
drug interactions
duplex ultrasound
dysarthria
dysnomia
dysphagia
dystonia
dystonia, focal
efficacy
electrocardiogram, abnormal
electrophoresis, lipoprotein
embolism
embolism, platelet
endarterectomy, carotid
endocarditis
endocarditis, marantic
entrapment neuropathy
enzyme inhibition
enzyme, defect
enzyme, muscle disease
enzyme, serum
epidemiology of neurology
evidence-based research
exercise
exercise intolerance
exercise-induced neurologic dysfunction
ezetimibe
falling
familial
fat
fat redistribution
fatigue
fibrinogen
Fisher C.M.
fluctuate
fruits
gait disorder
gaze palsy, supranuclear
gender
gene mutation
genetic neurologic disorders
globus pallidus, lesion of
globus pallidus, lesion of, bilateral
glucose level, serum
glucose tolerance test, abnormal
grasp reflex
headache
headache, children
heart murmur
hemianopia, homonymous
hemiparesis
hepatomegaly
hepatosplenomegaly
HMGcoA reductase inhibitors
human immunodeficiency virus type 1
hydrocephalus
hyperbilirubinemia
hypercholesterolemia
hyperglycemia
hyperlipidemia
hyperlipoproteinemia
hypertension
hypertriglyceridemia
hypoglycemia
hyporeflexia
iatrogenic neurologic disorders
incoordination
indinavir
intellectual deterioration
intracerebral hemorrhage
intracerebral hemorrhage, recurrent
intracranial pressure, increased
intrathecal medication
jaundice
jaw jerk, abnormal
keratitis
lactic dehydrogenase(LDH)
lacunar infarction
learning disability, in children
left-right orientation
leg weakness, bilateral
leukocyte alkaline phosphotase
leukocytosis
leukodystrophy
life expectancy
lifestyle
lipid lowering agent
lipid storage myopathy
lipids
lipoproteins
lumbosacral plexopathy
lumbosacral plexus
lysosomal storage disease
memory, defect of recent
memory, impairment of
metabolic acidosis
metachromatic leukodystrophy
metachromatic leukodystrophy, adult onset
migraine
migraine, children
migraine, equivalents
migraine, late life
migraine, pathogenesis
migraine, visual symptoms in
migraine, without headache
mitral valve vegetation
mortality
moyamoya
moyamoya, adult
MRI
MRI, abnormal
MRI, CAT scan compared to
muscle biopsy
muscle cramp
muscle pain
muscle weakness
muscle weakness, proximal
myocardial infarction
myoglobinuria
myopathy
myopathy, drug-induced
myopathy, metabolic
myopathy, necrotizing
myopathy, necrotizing, autoimmune
myopathy, necrotizing, immune-mediated
myopathy, proximal
nausea and vomiting
neck weakness
nelfinavir
neoplasm, primary intracerebral
neoplasm, primary of CNS
neurologic complications of, surgery
neurologic disease, diagnoses of
neurologic examination
neuropathy
neuropathy, diabetic
neuropathy, hereditary peripheral
neuropathy, painful
neuropathy, peripheral
neuroprotective agents
Niemann-Pick disease
obesity
old age, neurology of
omega-3 fatty acids
ophthalmic migraine
oral contraceptives
pain
pain, flank
pain, leg
palmomental response
palpitations
paranoia
paresthesias
pericarditis
physical activity
plasmapheresis
platelet aggregation
platelet coagulant activity
platelet inhibiting drugs
pneumoencephalogram(PEG)
polycythemia, primary
polyneuropathy
practice guidelines
pravastatin
precipitating factors
premarin
prethrombotic state
prevention of neurologic disorders
prognosis
progressive neurologic disorder
protease inhibitor, HIV-1
protein C deficiency
proteinuria
psychiatric problems in neurologic disorders
quality of life
recurrent
renal stones
respiratory failure
retinal artery occlusion
retrovirus
review article
rhabdomyolysis
rifampin
risk factors
risk factors, modification
ritonavir
safety
saquinavir
seizure
seizure, laughing as manifestation
self-grasping
serum alanine aminotransferase
sickle cell prep.
simvastatin
SPARCL trial
speech disorder
splenomegaly
statin therapy
stem cell transplantation
steroid therapy, CNS treatment and complications with
stuttering
stuttering following CVA
suck reflex
systemic illness
systemic lupus erythematosus
tachycardia
Tangier's disease
tarsal tunnel syndrome
the metabolic syndrome
thrombocytopenia
thrombocytosis
thrombosis, cerebral
thrombotic thrombocytopenia purpura
ticlopidine
transient ischemic attack
treatment of neurologic disorder
triglycerides
ultrasonography
ultrasonography, carotid artery
upgaze
urinary sulfatidase excretion
urine, dark
vasculopathy
vegetables
viral infection
viral load
vision, kaleidoscopic
visual loss, transient
visual symptoms
vitamin E
vitamin supplementation
weakness
weakness, fluctuating
weakness, generalized
weakness, progressive
weakness, proximal
weight loss
white matter disease
xanthoma, intracranial
Showing articles 0 to 50 of 555 Next >>

A 23-Year-Old Woman Presenting with Cognitive Impairment and Gait Disturbance
Neurol 99:997-1003, Chaity,D.K.,et al, 2022

A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke
NEJM 382:9-19,81, Amarenco, P.,et al, 2020

Metabolic Lipid Muscle Disorders: Biomarkers and Treatment
Ther Adv Neurol Disord 12:1-15, Angelini, C.,et al, 2019

Cholesterol Lowering and Prevention of Stroke
Stroke 50:537-541, Hackam, D.G. & Hegele, R.A., 2019

Intrathecal 2-hydroxypropyl-�-cyclodextrin Decreases Neurological Disease Progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial
Lancet 390:1758-1768, Ory, D.S.,et al, 2017

A 45-year-old man with Weakness and Myalgia after Orthopedic Surgery
Neurol 88:e185-e189, Vazquez do Campo, R.,et al, 2017

A Case of Statin-Associated Autoimmune Myopathy
Clin Med Insights: Case Reports 10:1-4, Sweidan, A.J.,et al, 2017

Mystery Case: A 63-year-old Man with Progressive Proximal Pain and Weakness
Neurol 82:e26-e29, Scripko, P.D.,et al, 2014

Analysis of 1008 Consecutive Patients Aged 15 to 49 with First-Ever Ischemic Stroke: The Helsinki Young Stroke Registry
Stroke 40:1195-1203, Putaala,J.,et al, 2009

Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes
Stroke 40:1405-1409, Amarenco,P.,et al, 2009

Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
Stroke 40:3526-3531,3413, Goldstein,L.,et al, 2009

Interventions in the Management of Serum Lipids for Preventing Stroke Recurrence
Stroke 40:e622-e623, Manktelow,B. &Potter,J., 2009

Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population
JAMA 300:2142-1252, Freiberg,J.J.,et al, 2008

Relative Effects of Statin Therapy on Stroke and Cardiovascular Events in Men and Women: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study
Stroke 39:2444-2448, Goldstein,L.B.,et al., 2008

Statin Treatment and the Occurrence of Hemorrhagic Stroke in Patients With a History of Cerebrovascular Disease
Stroke 39:497-502, Vergouwen,M.D.I.,et al, 2008

Progress in Secondary Stroke Prevention
Ann Neurol 63:418-427, Romano,J.G. &Sacco,R.L., 2008

Hemorrhagic Stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Study
Neurol 70:2364-2370,2355, Goldstein,L.B.,et al, 2008

Risk Factors for Intracerebral Hemorrhage in a Pooled Prospective Study
Stroke 38:2718-2725, Sturgeon,J.D.,et al, 2007

Vascular Risk Factors and Diabetic Neuropathy
NEJM 352: 341-350, 408, Tesfaye, S., et al, 2005

Components of the Metabolic Syndrome and Risk for First-Ever Acute Ischemic Nonembolic Stroke in Elderly Subjects
Stroke 36:1372-1376, Milionis,H.J.,et al, 2005

Efficacy and Safety of Cholesterol-Lowering Treatment: Prospective Meta-Analysis of Data from 90056 Participants in 14 Randomised Trials of Statins
Lancet 366:1267-1278, Cholesterol Treatment Trialists (CTT) Collaborators, 2005

Effects of Cholesterol-lowering with Simvastatin on Stroke and Other Major Vascular Events in 20 536 People with Cerebrovascular Disease or Other High-Risk Conditions
Lancet 363:757-767, Heart Protection Study Collaborative Group, 2004

Cholesterol is Associated with Stroke But is Not a Risk Factor
Stroke 35:1524-1525,1526, Thrift,A.G., 2004

Cholesterol as a Risk Factor for Stroke
Stroke 35:1523-1524,1526, Piechowski-Jozwiak,B. &Bogousslavsky,J., 2004

Dietary Fat Intake and Risk of Stroke in Male US Healthcare Professionals: 14 Year Prospective Cohort Study
BMJ 327:777-781, He,K.,et al, 2003

Cholesterol and the Risk of Ischemic Stroke
Stroke 34:2930-2934, Bowman,T.S.,et al, 2003

Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 34:105-110, Lalouschek,W.,et al, 2003

New Evidence for Stroke Prevention
JAMA 288:1388-1395, Straus,S.E.,et al, 2002

Prospective Assessment of Risk Factors for Recurrent Stroke During Childhood--A 5-year Follow-up Study
Lancet 360:1540-1545,1526, Strater,R.,et al, 2002

Prognostic Importance of Leukoaraiosis in Patients with Symptomatic Internal Carotid Artery Stenosis
Stroke 33:1651-1655, Streifler,J.Y.,et al, 2002

Primary Prevention of Ischemic Stroke
Stroke 32:280-299, Goldstein,L.B.,et al, 2001

High-Density Lipoprotein Cholesterol and Ischemic Stroke in the Elderly
JAMA 285:2729-2735, Sacco,R.L.,et al, 2001

Statins for Stroke Prevention?
Lancet 357:1548-1549, Sandercock,P., 2001

Cholesterol and Strokes
BMJ 320:459-460, Oliver,M.F., 2000

HMG-CoA Reductase Inhibitors (Statins)
Neurol 54:790-795, Hess,D.C.,et al, 2000

Serum Lipids in Young Patients with Ischaemic Stroke: A Case-control Study
JNNP 69:29-33, Albucher,J.F. et al, 2000

Pravastatin Therapy and The Risk of Stroke
NEJM 343:317-326, White,H.D. et al, 2000

Statins and the Risk of Dementia
Lancet 356:1627-1631, Jick,H.,et al, 2000

Low-Density Lipoprotein Cholesterol and the Risk of Dementia with Stroke
JAMA 282:254-260, Moroney,J.T.,et al, 1999

Is Cholesterol a Risk Factor for Stroke? No
Arch Neurol 56:1521-1524, Landau,W.M., 1999

Is Cholesterol a Risk Factor for Stroke? Yes
Arch Neurol 56:1518-1520,1524, Demchuk,A.M.,et al, 1999

Stroke Patterns of Internal Carotid Artery Dissection in 40 Patients
Stroke 29:2646-2648, Lucas,C.,et al, 1998

Effect of HMGcoA Reductase Inhibitors on Stroke, A Meta-Analysis of Controlled Trials
Ann Int Med 128:89-95, Bucher,H.C.,et al, 1998

HIV-Protease Inhibitors
NEJM 338:1281-1292, Flexner,C., 1998

Migrainous Visual Accompaniments are not Rare in Late Life:The Framingham Study
Stroke 29:1539-1543, Wijman,C.A.C.,et al, 1998

Vascular Effects of Statins in Stroke
Stroke 28:2315-2320, Delanty,N.&Vaughan,C.J., 1997

High-Density Lipoprotein Cholesterol & Risk of Ischemic Stroke Mortality:21-Yr FU of 8586 Men-Israeli Ischemic Heart Dis Study
Stroke 28:83-87, Tanne,D.,et al, 1997

Cumulative Effects of High Cholesterol Levels, High Blood Pressure, & Cigarette Smoking on Carotid Stenosis
NEJM 337:516-522, Wilson,P.W.F.,et al, 1997

Influence of Cholesterol on Survival After Stroke:Retrospective Study
BMJ 314:1584-1588, Dyker,A.G.,et al, 1997



Showing articles 0 to 50 of 555 Next >>